Gordonsville, VA, October 16, 2006 - PBM Products, LLC, has purchased the exclusive worldwide rights to Profylac®, a hypoallergenic infant formula. The whey-based product is easy-to-digest and formulated for infants with severe food allergies, including infants who are allergic to cow's milk. A deal has been finalized with Danish companies Arla Foods Ingredients and ALK-Abelló that will extend PBM's geographic distribution to Europe.
“This is a sophisticated, state-of-the-art, allergy formula for PBM,” said company EVP, Jack Schramm. “We are manufacturing the Profylac in our factory in Vermont for the global market now, and are already preparing for FDA approval to sell this specially formulated product in the USA. It will be the first whey-based hypoallergenic infant formula with DHA in the United States. The new formula will be an affordable, and we believe, superior, alternative to currently available products.”
Launched in 1990, Profylac is one of the world’s most documented, extensively hydrolyzed infant formulas. Clinical studies have confirmed the product’s suitability for babies with cow’s milk and soy allergy—providing essential nutrition from birth.
Profylac is patented in 19 countries worldwide, where it continues to be available as a brand and as a private-label product from PBM.
PBM’s hypoallergenic formula will be manufactured by PBM Nutritionals in the only ISO 9001:2000–certified, infant formula–manufacturing facility in the United States. PBM Nutritionals is also approved by Quality Assurance International (QAI) to manufacture organic milk-based powder infant formula that is compliant with the comprehensive USDA organic regulations. Located in northwestern Vermont, the facility has been manufacturing infant formulas for more than 20 years.